As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly redesigning their menus offering customers scaled-down portions at lower prices, whether theyre on the drugs or not
[PubMed]11
Mathieu C, Zinman B, Hemmingsson JU et al (2016) Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial
Considering strong demand, it plans to scale capacity from 40 million to 150 million units, with a portion of the expansion cost funded by customers
Dietary changes, probiotics, and prebiotics have been shown to be the most effective, while FMT/WMT shows promising, but experimental potential, and antibiotic therapies are limited with regard to safety and the evidence base in clinical practice
However, clinical trials have yielded mixed results, failing to consistently enhance insulin sensitivity in T2DM [205]